| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
We are studying oncolytic viral(OV) therapy as a new therapeutic modality for malignant glioma. In OV therapy-induced changes of the several proangiogenic factors, we confirmed the significant, induction of cysteine-rich protein 61(CYR61) gene expression in tumors treated to OV. We are exploring the influence of angiotome such as CYR61 on OV therapy and continue to make new OV.
|
